Fusion Antibodies plc (LON:FAB) Insider Richard John Buick Acquires 94,825 Shares of Stock

Fusion Antibodies plc (LON:FAB) insider Richard John Buick purchased 94,825 shares of the business’s stock in a transaction on Monday, September 9th. The shares were bought at an average cost of GBX 3 ($0.04) per share, with a total value of £2,844.75 ($3,720.09).

Fusion Antibodies Stock Performance

LON:FAB opened at GBX 3.30 ($0.04) on Tuesday. The firm has a market capitalization of £3.15 million, a PE ratio of -82.50 and a beta of 0.48. The company has a debt-to-equity ratio of 3.23, a quick ratio of 2.36 and a current ratio of 3.26. The stock has a 50-day simple moving average of GBX 3.22 and a two-hundred day simple moving average of GBX 3.51. Fusion Antibodies plc has a 52-week low of GBX 2.80 ($0.04) and a 52-week high of GBX 9.50 ($0.12).

Fusion Antibodies Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.